Hims & Hers Health, Inc. (HIMS) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Hims & Hers Health, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 4, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnHIMS vs TMDX

growth of $100 · dividends reinvested · last 7y
HIMS +214.5%TMDX +229.5%TMDX compounded faster
0200400600Start $100202120232025$314$329
HIMS TMDX

HIMS vs TMDX: by the numbers

  • HIMS is the larger company ($7.04B vs $2.80B market cap).
  • TMDX is profitable (27.04% net margin) while HIMS runs a net loss (-0.56%).
  • TMDX grew revenue faster over the past five years (90.79% vs 69.19% CAGR).

Metrics side by side

Valuation

MetricHIMSTMDX
P/E ratioN/A18.66
Forward P/EN/A44.58
P/S ratio2.974.64
P/B ratio15.775.97
PEG ratioN/A0.05
EV / EBITDA79.9426.33
FCF yield1.08%5.13%

Profitability

MetricHIMSTMDX
Gross margin67.64%59.09%
Operating margin1.32%14.85%
Net margin-0.56%27.04%
ROE-2.97%34.80%
ROIC6.02%10.94%

Growth (annualized)

MetricHIMSTMDX
Revenue CAGR (5Y)69.19%90.79%
Total return CAGR (5Y)30.42%23.91%

Frequently asked

Which has grown faster, HIMS or TMDX?
Over the past five years, TMDX grew revenue faster — HIMS at a 69.19% CAGR versus TMDX at 90.79%.
Is HIMS or TMDX more profitable?
TMDX runs the higher net margin — HIMS at -0.56% versus TMDX at 27.04%.
How have HIMS and TMDX total returns compared?
Over the past 5 years, HIMS delivered 30.42% and TMDX delivered 23.91% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 4, 2026.